This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Stock Rises 11.8% in 3 Months: More Room to Run?
by Zacks Equity Research
MetLife's (MET) strong performing U.S. and Asia business, coupled with cost-reduction initiatives, position the company well for growth.
MET vs. PUK: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MET vs. PUK: Which Stock Is the Better Value Option?
Are Investors Undervaluing Aegon (AEG) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Invesco S&P 500 Equal Weight Financials ETF (RSPF) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPF
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
MetLife (MET) Unveils Solutions to Boost Footprint in Asia
by Zacks Equity Research
MetLife (MET) launches 360Health in Nepal and 360Future in Korea to empower its clients to effectively manage their health conditions and enjoy a happy retirement life.
MetLife (MET) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Is SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for KIE
MetLife (MET) Down 1.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)?
by Zacks Equity Research
Sector ETF report for RSPF
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
by Zacks Equity Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
MetLife (MET), Empathy to Offer Enhanced Bereavement Services
by Zacks Equity Research
MetLife (MET) makes Empathy's bereavement care platform available to its customers so that families can better handle administrative hassles and get emotional support following the loss of a loved one.
MetLife (MET) Stock Rises 19.5% in 3 Months: More Room to Run?
by Zacks Equity Research
MetLife's (MET) cost-curbing initiatives are likely to lower expenses, increase efficiency and boost profit levels.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
MetLife (MET) Ventures Into Single Family Rental Space in the US
by Zacks Equity Research
MetLife's (MET) asset management arm, MetLife Investment Management, ventures into single-family rental space with a new fund, securing capital commitments of $390 million.
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Top Research Reports for Verizon, ICICI Bank & MercadoLibre
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), ICICI Bank Limited (IBN) and MercadoLibre, Inc. (MELI).
MetLife (MET) Q2 Earnings Beat on Higher Investment Returns
by Zacks Equity Research
MetLife (MET) exits the second quarter with cash and cash equivalents of $15,417 million.
MetLife (MET) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for MetLife (MET) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
MetLife (MET) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 4.86% and 8.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?